RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aytu BioScience Stock

Aytu BioScience EBIT 2024

Aytu BioScience EBIT

-2.89 M USD

Ticker

AYTU

ISIN

US0547548745

WKN

A2QJRT

In 2024, Aytu BioScience's EBIT was -2.89 M USD, a -74.66% increase from the -11.4 M USD EBIT recorded in the previous year.

The Aytu BioScience EBIT history

YEAREBIT (undefined USD)
2030e-
2029e1.12
2028e-1.73
2027e10.72
2026e5.46
2025e3.23
2024-2.89
2023-11.4
2022-34.4
2021-38.2
2020-20.9
2019-16.9
2018-17.8
2017-18.8
2016-14.2
2015-7.6
2014-0.1
2013-0.1
2012-0.1
2011-0.1
2010-0.1
2009-0.1
2008-0.1
2007-

Aytu BioScience Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Aytu BioScience, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Aytu BioScience from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Aytu BioScience’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Aytu BioScience. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Aytu BioScience’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Aytu BioScience’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Aytu BioScience’s growth potential.

Aytu BioScience Revenue, EBIT and net profit per share

DateAytu BioScience RevenueAytu BioScience EBITAytu BioScience Net Income
2030e141.07 M undefined0 undefined0 undefined
2029e131.89 M undefined1.12 M undefined0 undefined
2028e123.73 M undefined-1.73 M undefined0 undefined
2027e120.05 M undefined10.72 M undefined-2.06 M undefined
2026e71 M undefined5.46 M undefined3.45 M undefined
2025e71.75 M undefined3.23 M undefined1.44 M undefined
202481 M undefined-2.89 M undefined-15.84 M undefined
2023107.4 M undefined-11.4 M undefined-17.1 M undefined
202296.7 M undefined-34.4 M undefined-108.8 M undefined
202165.6 M undefined-38.2 M undefined-58.3 M undefined
202027.6 M undefined-20.9 M undefined-13.6 M undefined
20197.3 M undefined-16.9 M undefined-27.1 M undefined
20183.7 M undefined-17.8 M undefined-10.2 M undefined
20173.2 M undefined-18.8 M undefined-22.5 M undefined
20162.6 M undefined-14.2 M undefined-28.2 M undefined
2015300,000 undefined-7.6 M undefined-7.7 M undefined
20140 undefined-100,000 undefined-100,000 undefined
20130 undefined-100,000 undefined-100,000 undefined
20120 undefined-100,000 undefined-100,000 undefined
20110 undefined-100,000 undefined-100,000 undefined
20100 undefined-100,000 undefined-100,000 undefined
20090 undefined-100,000 undefined-100,000 undefined
20080 undefined-100,000 undefined-100,000 undefined
20070 undefined0 undefined0 undefined

Aytu BioScience stock margins

The Aytu BioScience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Aytu BioScience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Aytu BioScience.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Aytu BioScience's sales revenue. A higher gross margin percentage indicates that the Aytu BioScience retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Aytu BioScience's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Aytu BioScience's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Aytu BioScience's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Aytu BioScience. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Aytu BioScience's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Aytu BioScience Margin History

Aytu BioScience Gross marginAytu BioScience Profit marginAytu BioScience EBIT marginAytu BioScience Profit margin
2030e67.39 %0 %0 %
2029e67.39 %0.85 %0 %
2028e67.39 %-1.4 %0 %
2027e67.39 %8.93 %-1.71 %
2026e67.39 %7.69 %4.86 %
2025e67.39 %4.5 %2.01 %
202467.39 %-3.57 %-19.56 %
202362.01 %-10.61 %-15.92 %
202254.08 %-35.57 %-112.51 %
202144.51 %-58.23 %-88.87 %
202072.83 %-75.72 %-49.28 %
201969.86 %-231.51 %-371.23 %
201843.24 %-481.08 %-275.68 %
201756.25 %-587.5 %-703.13 %
201661.54 %-546.15 %-1,084.62 %
201566.67 %-2,533.33 %-2,566.67 %
201467.39 %0 %0 %
201367.39 %0 %0 %
201267.39 %0 %0 %
201167.39 %0 %0 %
201067.39 %0 %0 %
200967.39 %0 %0 %
200867.39 %0 %0 %
200767.39 %0 %0 %

Aytu BioScience Aktienanalyse

What does Aytu BioScience do?

Aytu BioScience Inc. is a pharmaceutical company based in Englewood, Colorado. The company was founded in 2015 by Joshua Disbrow, who previously worked at Arbor Pharmaceuticals and Avadel Pharmaceuticals. Aytu specializes in the development of medications and medical products focused on respiratory diseases, infectious diseases, and urology. One of their main products is Natesto, a gel used to administer testosterone to men with low testosterone levels. They also have Tuzistra XR, an extended-release cough medicine, and a partnership with Kitov Pharma for the distribution of Consensi, a combination medication for high blood pressure and osteoarthritis. Another important product is MiOXSYS, a non-invasive diagnostic test for assessing male fertility. Aytu also has a business model focused on acquiring established products, such as ZolpiMist for sleep disorders, FemiNAT for cervical cancer testing, and Healight for HIV testing. They collaborate with other companies to develop new technologies and acquire products, such as Urology Health Solutions with Innovus Pharmaceuticals and INTERCEPT Blood Platelets and Plasma with Cerus Corporation. Overall, Aytu BioScience Inc. is an innovative company focused on the development and acquisition of products in the areas of respiratory diseases, infectious diseases, and urology, with the potential to improve many people's lives and revolutionize the pharmaceutical industry. Aytu BioScience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Aytu BioScience's EBIT

Aytu BioScience's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Aytu BioScience's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Aytu BioScience's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Aytu BioScience’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Aytu BioScience stock

How much did Aytu BioScience achieve in EBIT for the current year?

In the current year, Aytu BioScience has achieved an EBIT of -2.89 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Aytu BioScience.

How has the EBIT of Aytu BioScience developed in recent years?

The EBIT of Aytu BioScience has increased by -74.658% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Aytu BioScience?

The EBIT of Aytu BioScience is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Aytu BioScience pay?

Over the past 12 months, Aytu BioScience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aytu BioScience is expected to pay a dividend of 0 USD.

What is the dividend yield of Aytu BioScience?

The current dividend yield of Aytu BioScience is .

When does Aytu BioScience pay dividends?

Aytu BioScience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aytu BioScience?

Aytu BioScience paid dividends every year for the past 0 years.

What is the dividend of Aytu BioScience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aytu BioScience located?

Aytu BioScience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aytu BioScience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aytu BioScience from 12/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/8/2024.

When did Aytu BioScience pay the last dividend?

The last dividend was paid out on 12/8/2024.

What was the dividend of Aytu BioScience in the year 2023?

In the year 2023, Aytu BioScience distributed 0 USD as dividends.

In which currency does Aytu BioScience pay out the dividend?

The dividends of Aytu BioScience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Aytu BioScience stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Aytu BioScience

Our stock analysis for Aytu BioScience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aytu BioScience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.